Heart and Soul: Innovative Patient-Centered Care Leads to Excellence in Cardiac Clinical Trials | Sponsored Features
“There are very few sites in the United States that have been chosen to do this,” Dr. Latacha said. “We had to go through a fairly thorough selection process.”
Methodist’s Cardiac, Vascular and Pulmonary clinical trials team, which currently runs 18 active studies with more than 60 enrolled participants, has not lost a patient to follow-up since 2015. In other words, no participant chose to discontinue follow-up care or visits after enrolling in a study.
“We care,” McMartin added. “were The meaning of care. It’s not about money or numbers for us. We want someone else’s mother, son or best friend to be safe and healthy. We treat them as individuals rather than numbers.
According to McMartin, this is what produces good data and makes Methodist so attractive to clinical research organizations tasked with selecting the best and most reliable sites for their studies.
Steve Sewell, a field engineer for EBR Systems Inc., agrees. The meaning of carehe said, is just the beginning of why Methodist was chosen for the SOLVE-CRT study.
“We work across the country,” he said. “What I love about Methodist is the feel – the atmosphere. The equipment is nice. The rooms are spacious. Dr. Latacha is passionate about this procedure and the staff are fantastic. But the passion for the patients – making sure we get the best candidates and they get the best results – that’s what comes out.